;
Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Bicycle raising L20M A round

    Bicycle Therapeutics Ltd. (Cambridge, U.K.) raised an undisclosed amount of a planned L20 million ($32.2 million) series A round from existing investors Atlas Venture; Novartis Venture Fund; SR One; SV Life Sciences; …

    Published on 10/14/2014
  • FINANCIAL NEWS: Cancer play Rigontec raises EUR 9.5M

    Rigontec GmbH (Siegburg, Germany) raised EUR 9.5 million ($12 million) in the first close of a series A round co-led by Wellington Partners and Boehringer Ingelheim Venture Fund. NRW Bank and High-Tech Greunderfonds …

    Published on 10/14/2014
  • FINANCIAL NEWS: DNAtrix raises $20M in series B

    Cancer play DNAtrix Inc. (Houston, Texas) raised $20 million in an untranched series B round led by new investor Morningside Ventures. Existing investors Mercury Fund, Targeted Technology Fund and unnamed others also …

    Published on 10/14/2014
  • FINANCIAL NEWS: Esperion planning $85M follow-on

    Esperion Therapeutics Inc. (NASDAQ:ESPR) proposed to raise up to $85 million in a follow-on underwritten by J.P. Morgan and BofA Merrill Lynch. The offering will help fund Phase III testing of ETC-1002, which is an …

    Published on 10/14/2014
  • FINANCIAL NEWS: Raze debuts with $24M series A

    Raze Therapeutics Inc. (Cambridge, Mass.) raised $24 million in a series A round with Atlas Venture; MPM Capital; MS Ventures; Partners Innovation Fund; Astellas Venture Management; and Novartis AG (NYSE:NVS; SIX:NOVN…

    Published on 10/14/2014
  • FINANCIAL NEWS: Anatara raises A$7M in Australian IPO

    Anatara Lifesciences Ltd. (ASX:ANR), which is seeking partners for human development of its non-antibiotic therapy to treat and prevent diarrhea, raised A$7 million ($6.1 million) through the sale of 14 million shares …

    Published on 10/13/2014
  • FINANCIAL NEWS: Invitae raises $120M in F round

    Invitae Corp. (San Francisco, Calif.) raised $120 million in a series F round to build out its one-stop genetic testing service. The company aims to aggregate a complete catalog of genetic diagnostic tests and offer …

    Published on 10/13/2014
  • FINANCIAL NEWS: Nextech raises $40M for Oncology IV fund

    Nextech Invest Ltd. raised the first $40 million of its planned $100 million Oncology IV fund, which it expects to close in the next 12 months. The firm intends to invest in eight to 10 companies developing cancer …

    Published on 10/13/2014
  • FINANCIAL NEWS: Probiodrug sets IPO terms

    Probiodrug AG (Halle/Saale, Germany) set a price range for its proposed IPO on Euronext Amsterdam. The Alzheimer's company plans to sell 1.5 million shares at EUR 15.25-EUR 19. At the midpoint price of EUR 17.13, …

    Published on 10/10/2014
  • FINANCIAL NEWS: PTC raises $108.8M in follow-on

    PTC Therapeutics Inc. (NASDAQ:PTCT) added $108.8 million to its coffers with its second big follow-on of 2014, selling 3 million shares at $36.25 in a deal underwritten by Credit Suisse; Citigroup; Cowen; Deutsche Bank;…

    Published on 10/10/2014
  • FINANCIAL NEWS: AutoGenomics files for IPO

    AutoGenomics Inc. (Vista, Calif.) filed to raise up to $60 million in an IPO on NASDAQ underwritten by Stifel; Canaccord Genuity; and Cantor Fitzgerald. The IPO filing is the company's third attempt to go public. …

    Published on 10/8/2014
  • FINANCIAL NEWS: Histogenics files for IPO

    Histogenics Corp. (Waltham, Mass.) filed to raise up to $65 million in an IPO on NASDAQ underwritten by Cowen; Needham; Cannaccord Genuity; and BTIG. Histogenics' NeoCart is in Phase III testing to repair knee cartilage…

    Published on 10/8/2014
  • FINANCIAL NEWS: Levicept raises L10M series A

    Levicept Ltd. (Sandwich, U.K.) raised L10 million ($16 million) in a series A round with Advent Life Sciences, Gilde Healthcare and Index Ventures.The biotech's LEVI-04 (p75NTR-Fc) is in preclinical development to treat…

    Published on 10/7/2014
  • FINANCIAL NEWS: Magnus raises L15.5M for its asset bundle

    Magnus Life Science (London, U.K.), a new company housed at University College London, raised L15.5 million ($24.8 million) in seed funding from an unnamed European private equity investor. Magnus said it has five …

    Published on 10/7/2014
  • FINANCIAL NEWS: Proteon sets IPO terms

    Proteon Therapeutics Inc. (Waltham, Mass.) set a price range for its proposed IPO on NASDAQ. The company hopes to sell 4.7 million shares at $12-$14. At $13, Proteon would raise $61.1 million and be valued at $182.6 …

    Published on 10/7/2014
  • FINANCIAL NEWS: TVM closes Fund VII at $201.6M

    TVM Capital Life Science announced the final closing of its TVM Life Science Ventures VII at $201.6 million.Lead investors included Teralys Capital and Eli Lilly and Co. (NYSE:LLY). Also participating were Business …

    Published on 10/6/2014
  • FINANCIAL NEWS: Virobay, Xenon set IPO terms

    Virobay Inc. (Menlo Park, Calif.) and Xenon Pharmaceuticals Inc. (Burnaby, B.C.) both set terms for their proposed IPOs on NASDAQVirobay plans to sell 3.8 million shares at $12-$14. At $13, Virobay would raise $50 …

    Published on 10/6/2014
  • FINANCIAL NEWS: Dermira raises $125 million in upsized IPO

    Dermira Inc. (NASDAQ:DERM) shed $0.45 to $15.55 in its first day of trading after the dermatology company raised $125 million through the sale of 7.8 million shares at $16 in an IPO on NASDAQ. Concurrently, partner UCB …

    Published on 10/3/2014
  • FINANCIAL NEWS: Forbion raises EUR 92M toward FCF III

    Forbion Capital Partners has raised the first EUR 92 million ($116.6 million) of a planned EUR 150-EUR 200 million fund, named FCF III. The firm said the final close could be more than 12 months away, but it expects …

    Published on 10/3/2014
  • FINANCIAL NEWS: Portola prices $161.2M follow-on

    Portola Pharmaceuticals Inc. (NASDAQ:PTLA) added $1.10 on Friday to close at $27.60 after announcing late Thursday that it had priced 6.2 million shares at $26 in a follow-on that it said is expected to close on Oct. 8.…

    Published on 10/3/2014
  • FINANCIAL NEWS: Vital goes back for $35M in follow-on

    Liver disease company Vital Therapies Inc. (NASDAQ:VTL) raised $35 million through the sale of 2 million shares at $17.50 in a follow-on underwritten by BofA Merrill Lynch; William Blair, Canaccord Genuity; and SunTrust…

    Published on 10/3/2014
  • FINANCIAL NEWS: Calithera raises $80M in IPO

    Calithera Biosciences Inc. (NASDAQ:CALA) fell $0.59 to $9.41 in its first day of trading on NASDAQ after it raised $80 million through the sale of 8 million shares at $10 on Thursday. The IPO, underwritten by Citigroup;…

    Published on 10/2/2014
  • FINANCIAL NEWS: Forward Pharma sets range for big IPO

    Forward Pharma A/S (Copenhagen, Denmark) amended its IPO on NASDAQ and now plans to sell 9.5 million ADSs at $20-$22. At the $21 midpoint, the company would raise $200 million and be valued at $941.6 million. It filed …

    Published on 10/2/2014
  • FINANCIAL NEWS: Radius raises $50.2M in follow-on

    Radius Health Inc. (NASDAQ:RDUS) raised $50.2 million through the sale of 2.75 million shares at $18.25 in a follow-on underwritten by Jefferies; Cowen; and Cantor Fitzgerald. The company proposed the offering in a …

    Published on 10/2/2014
  • FINANCIAL NEWS: Visterra raises $30M in series B

    Visterra Inc. (Cambridge, Mass.) raised $30 million in a series B round led by new investors Merck Research Labs Venture Fund; Vertex Venture Holdings Ltd.; and Temasek. New investor Cycad Group and existing investors …

    Published on 10/2/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993